Template:Mecamylamine: Difference between revisions

Latest revision as of 18:02, 12 March 2014

Mecamylamine
Mecamylamine tablet^®, Vecamyl^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Mecamylamine
ClinicalTrials.gov

@@ Line 2: / Line 2: @@
 ! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Mecamylamine|{{fontcolor|#6C7B8B|Mecamylamine}}]]'''''
 |-
-! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | MECAMYLAMINE tablet<sup>®</sup>, VECAMYL<sup>®</sup> FDA Package Insert
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Mecamylamine tablet<sup>®</sup>, Vecamyl<sup>®</sup> FDA Package Insert
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Mecamylamine indications and usage|Indications and Usage]]
@@ Line 34: / Line 34: @@
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Mecamylamine labels and packages|Labels and Packages]]
 |-
-! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on XXXXX
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Mecamylamine
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
 |-
 |}